Cytomegalovirus hepatitis associated with use of anti-tumor necrosis factor-alpha antibody.
Mizuta
Mari
M
Schuster
Mindy G
MG
D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D000998:Antiviral Agents / Q000627:therapeutic use; D003586:Cytomegalovirus Infections / Q000139:chemically induced* / Q000188:drug therapy; D005260:Female; D015774:Ganciclovir / Q000627:therapeutic use; D005765:Gastrointestinal Agents / Q000009:adverse effects*; D006525:Hepatitis, Viral, Human / Q000139:chemically induced* / Q000188:drug therapy; D006801:Humans; D000069285:Infliximab; D008875:Middle Aged
D000911:Antibodies, Monoclonal; D000998:Antiviral Agents; D005765:Gastrointestinal Agents; D000069285:Infliximab; D015774:Ganciclovir